Introduction
Myocardial infarction (MI) occurs as a result of coronary artery occlusion and carries a risk of in-hospital mortality.Reference Thygesen, Alpert and Jaffe1 Coronary angiography (CAG) procedures performed before permanent myocardial damage occurs reduce this risk.Reference Granger, Goldberg and Dabbous2 Regular outpatient clinical follow-ups are critical for reducing long-term mortality. International guidelines and studies emphasize that regular follow-ups after MI enhance treatment success, prevent early complications, and reduce long-term mortality.Reference Virani, Newby and Arnold3–Reference Schiele, Quignot and Khachatryan6 Therefore, clinical follow-up non-adherence (CFNA) should be identified and addressed in the early period. CFNA is a multifaceted phenomenon in the literature, with its definition varying depending on different follow-up strategies and the nature of diseases. Researchers often develop their own definitions based on a referenced study. Although there are differences among these definitions, the generally accepted view defines CFNA as the failure to attend the minimum number of appointments necessary to prevent adverse outcomes of the monitored disease.Reference Agbla and DiazOrdaz7–Reference Patel, Pak and Abramson10 CFNA is influenced by various social determinants of health (SDH), such as demographic, psychosocial, economic, and logistical factors.Reference Patel, Pak and Abramson10–Reference Jimenez, Quiroz and Sanchez12
One of the situations that destabilizes these determinants and leads to adverse outcomes is disasters, such as earthquakes, which cause physical destruction. Earthquakes represent large-scale crises that create disadvantaged groups in terms of health. Displaced individuals affected by the disaster reside in container cities and prefabricated structures, facing temporary housing challenges (THC).Reference Ke, Liu and Li13 THC leads to issues such as poor hygiene, social isolation, and inadequate access to health care services. This situation, combined with psychological effects, can worsen health outcomes.Reference Sarı, Taşdelen-Karçkay and Tarcan14, Reference Liao15 This situation may negatively affect clinical outcomes and access to health care services during the post-disaster recovery process, thereby increasing the risk of CFNA.
The 2023 Türkiye earthquake caused massive destruction in 11 provinces, resulting in thousands of fatalities and disruptions to living conditions (GLIDE number: EQ-2023-000015-TUR).Reference Sarı, Taşdelen-Karçkay and Tarcan14 Individuals living in the earthquake-exposed and affected areas constitute a disadvantaged population compared to those living in unaffected areas. THC exposure may worsen the clinical outcomes and post-discharge follow-up of MI patients in this group.
This retrospective cohort study evaluates the effects of THC on CFNA and achieving target low-density lipoprotein cholesterol (LDL-C) levels during a 1-year follow-up in MI patients affected by the 2023 Türkiye earthquake in the Hatay region.
Before the earthquake, 6 hospitals in Hatay were equipped with coronary angiography (CAG) units. Three were completely destroyed and one was severely damaged and became non-operational. Although this hospital was repaired and reopened after 3 months, the rising health care demand led to the establishment of a new CAG unit at Dörtyol State Hospital, which became the region’s main referral center.
Following the disaster, 183 container settlements were set up across Hatay, accommodating over 205,000 people in 55,612 containers.16 CAG services were provided by 4 hospitals located 1-100 kilometers from these settlements. Patients in both container areas and permanent residences had similar access to hospitals. Although free transportation services were available, road infrastructure damage caused significant disruptions.
The study aims to contribute to the development of policies that identify the health care needs of cardiac patients affected by THC and reduce health care inequalities in the post-earthquake period.
Methodology
Study Design and Setting
This retrospective cohort study was conducted in Hatay, one of the provinces most affected by the February 6, 2023, Türkiye earthquake. The study aims to examine the relationship between THC and clinical follow-up adherence as well as long-term cardiovascular outcomes in the post-earthquake period. Patients diagnosed with MI and who underwent CAG and revascularization via stent implantation between May 6 and November 6, 2023, at Hatay Dörtyol State Hospital were included.
Patients were divided into 2 groups based on their post-earthquake living conditions: Group 1 (THC group) included those residing in container cities, while Group 2 (non-THC group) comprised those who continued to live in intact or usable homes. All included container cities were located in urban areas. The distance from patients’ residences in both groups to Hatay Dörtyol State Hospital ranged from 1 to 85 km, and the distance to the nearest hospital with a cardiology specialist was between 1 and 13 km.
Initially, the incidence of major adverse cardiac events (MACE) during the 1-year follow-up was compared between all patients. Subsequently, patients who developed MACE were excluded from further analysis, as the occurrence of such major clinical events may significantly alter follow-up protocols and lipid management strategies. This exclusion was implemented to minimize potential confounding.
Accordingly, CFNA and the rate of achieving target LDL-C levels were assessed among all patients who remained free of MACE throughout the 1-year follow-up. First-year laboratory results were analyzed only in patients who attended their first-year outpatient follow-up visit and did not experience MACE.
Exclusion Criteria
Patients who relocated to another city or changed their type of accommodation before the completion of follow-up, patients over the age of 75, and those with impaired self-care were excluded due to a potential for functional dependency that could compromise follow-up adherence; patients with inaccessible medical data, those undergoing revascularization strategies other than stent implantation, and patients undergoing CAG for indications other than MI were also excluded. Following the earthquake, all patients in the disaster area were provided with free health care services. However, 7 patients without prior health insurance also benefited from post-MI medical care but were not included in the study due to lack of access to their medical records, as they were not registered in the national insurance system.
Post-Discharge Follow-Ups
Follow-ups were scheduled for the 1st week, 1st month, 3rd month, 6th month, and 12th month after discharge. All visits were planned as face-to-face evaluations. Patients were provided with access to walk-in examinations and were informed at the time of discharge.
Participation rates were calculated separately for each scheduled follow-up period. Patients who attended fewer than 3 out of 5 appointments were defined as CFNA.Reference Ellis, McQueenie and McConnachie17
Data from patients followed up at other health care institutions were also collected through electronic health records and prescription information.
The planned 1-year follow-up period for the last patient included in the study was set to conclude on November 6, 2024. However, follow-up applications submitted between November 6 and 18, 2024, to accommodate delayed visits, were also included in the analysis as part of the 1-year follow-up period.
Data Collection and Definitions
Data were collected through electronic health records and patient declarations. In addition to basic demographic data, the proportions of myocardial infarction (MI) subgroups, including ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI), were recorded along with biochemical and hematological parameters (lipid profile, hemogram, electrolytes, inflammatory markers, renal function tests, and HbA1c) and ejection fraction (EF) measurements. STEMI was defined as the presence of MI symptoms accompanied by ST-segment elevation on electrocardiography, while NSTEMI was defined as elevated cardiac enzyme levels without prominent ST-segment elevation.Reference Byrne, Rossello and Coughlan4 MI diagnoses and EF measurements were performed by expert cardiologists. Risk factors were assessed according to guideline definitions, including the presence of diabetes mellitus (DM), hypertension (HT), and chronic obstructive pulmonary disease (COPD).Reference Agusti and Vogelmeier18–Reference Mancia, Kreutz and Brunström20
A file review was conducted to determine the total MACE rates. The patients were followed for MACE from the day of discharge until November 18, 2024.
Total MACE was defined as the composite of stent thrombosis requiring reintervention and hospitalizations due to worsening heart failure (WHF).Reference Thygesen, Alpert and Jaffe1, Reference McAllister, Halbesma and Carruthers21, Reference Qu, Wei and Du22 The LDL-C target was defined as <55 mg/dL, which is the recommended goal for patients with prior MI according to the European guidelines, and patients achieving this target were identified.Reference Byrne, Rossello and Coughlan4
Interventions
CAG procedures were performed by expert cardiologists in accordance with standard protocols. All patients were initiated on statin and dual antiplatelet therapy at discharge. Patients with systolic dysfunction received optimal medical therapy as recommended by the guidelines.Reference Byrne, Rossello and Coughlan4
Statistical Methods
The data were analyzed using IBM SPSS V27. Descriptive statistics for categorical variables were presented as frequencies and percentages, while quantitative variables were summarized using means, standard deviations, medians, and minimum-maximum values. Normality was assessed using the Kolmogorov-Smirnov and Shapiro-Wilk tests. For normally distributed continuous variables, the independent samples t-test was used to compare groups; for non-normally distributed variables, the Mann-Whitney U test was applied. Paired continuous variables were analyzed using the Paired Samples T-Test for normally distributed data and the Wilcoxon test for non-normally distributed data. A P-value of ≤0.05 was considered statistically significant.
In the logistic regression analysis, dependent variables included follow-up appointment attendance rates for each period, CFNA, and achievement of LDL-C targets. Independent variables comprised age, sex, risk factors present at discharge, pre-discharge EF values, MI subtypes (STEMI/NSTEMI), baseline and 1-year laboratory values, and the presence of THC.
The analysis results were presented as odds ratios (OR) with 95% confidence intervals (CI) to demonstrate the effects of independent variables. A statistical significance level of P ≤0.05 was established.
Ethical Considerations
This study was conducted in accordance with the guidelines of Good Clinical Practice and the principles outlined in the Declaration of Helsinki, ensuring the protection of patient rights and confidentiality. Ethical approval was obtained from the Ethics Committee of Hatay Mustafa Kemal University (approval no: 28/46-35/60). Since the study is retrospective in nature, written informed consent was not required for the review of patient data.
Results
Out of 517 CAG images reviewed, 283 patients met the inclusion criteria. Group 1 comprised 167 patients, while Group 2 included 116 patients.
No significant differences were observed between the groups in terms of age (Group 1: 62.44 ± 8.71 years; Group 2: 64.22 ± 7.12 years, P = 0.328), male gender (Group 1: 62.88%; Group 2: 65.52%, P = 0.856), DM (Group 1: 40.72%; Group 2: 39.65%, P = 0.217), HT (Group 1: 47.90%; Group 2: 50.86%, P = 0.482), or COPD (Group 1: 6.58%; Group 2: 5.18%, P = 0.690).
However, the incidence of STEMI was significantly higher in Group 1 compared to Group 2 (56.9% vs. 52.9%, P = 0.017). Additionally, no significant differences were found in pre-discharge EF values (Group 1: 45 [25-60]; Group 2: 50 [35-60], P = 0.718).
Laboratory Values
In the laboratory evaluations at admission, significantly higher levels of LDL-C (P = 0.027) and albumin (P = 0.021) were detected in Group 1. No statistically significant differences were observed between the groups in other biochemical and hematological parameters (Table 1). At the 1-year follow-up, Group 1 exhibited significantly higher levels of LDL-C (P <0.001), total cholesterol (P <0.001), potassium (P <0.001), albumin (P = 0.033), and HbA1c (P = 0.020), while e-GFR levels were significantly lower (P = 0.030) (Table 2).
Comparison of laboratory values at admission between 2 groups

Bold values are statistically significant (P < 0.05).
BUN: Blood urea nitrogen, CRP: C-reactive protein, e-GFR: estimated glomerular filtration rate, HbA1c: hemoglobin A1c, HCT: hematocrit, HDL: high-density lipoprotein, HGB: hemoglobin, LDL: low-density lipoprotein, PLT: platelet, SD: standard deviation, TC: total cholesterol, WBC: white blood cell
Comparison of laboratory values between 2 groups at 1-year follow-up

Bold values are statistically significant (P < 0.05).
BUN: Blood urea nitrogen, CRP: C-reactive protein, e-GFR: estimated glomerular filtration rate, HbA1c: hemoglobin A1c, HCT: hematocrit, HDL: high-density lipoprotein, HGB: hemoglobin, LDL: low-density lipoprotein, PLT: platelet, SD: standard deviation, TC: total cholesterol, WBC: white blood cell
Clinical Follow-Up Outcomes
A total of 34 patients experienced MACE during a total follow-up duration of 120,253 days, with an average follow-up of 419 days. The incidence of MACE was significantly higher in Group 1 compared to Group 2 (12.6% vs. 10.9%, P = 0.008). All MACEs occurred within the first 243 days. The number of days from discharge to MACE occurrence was significantly shorter in Group 1 (87 [19-193]) compared to Group 2 (102 [34-243]) (P = 0.021). Among the components of MACE, the rate of WHF was also significantly higher in Group 1 (13.70% vs. 5.83%, P = 0.034). Although the rate of stent thrombosis was higher in Group 1 (5.48% vs. 1.94%), this difference was not statistically significant (P = 0.141).
In analyses excluding patients who experienced MACE (Group 1: n = 146, Group 2: n = 103), the primary outcome, CFNA rate, was significantly higher in Group 1 compared to Group 2 (49.3% vs. 9.7%, P <0.001). Outpatient attendance rates during the follow-up periods (1st week, 1st month, 3rd month, 6th month, and 12th month) were significantly lower in Group 1 (Figure 1).
Attendance rates of groups during follow-up periods.
Attendance rates were significantly lower in the THC group across all time points. Both groups showed the highest attendance at the 12th month.

The rate of achieving LDL-C targets was significantly higher in Group 2 compared to Group 1 (31.07% vs. 6.85%, P <0.001). One-year EF values were similar between the groups (Group 1: 50 [35-60]; Group 2: 50 [40-60], P = 0.812).
Regression Analyses
Logistic regression analysis identified THC as an independent positive predictor for CFNA (OR: 1.925; CI: 1.113-3.329; P = 0.019) and total MACE rate (OR: 3.937; CI: 1.481-10.466; P = 0.006). Furthermore, THC was determined to be an independent negative predictor for follow-up attendance rates across all 5 follow-up periods (1st week: OR = 0.231, CI: 0.131-0.405, P <0.001; 1st month: OR = 0.382, CI: 0.208-0.702, P = 0.002; 3rd month: OR = 0.344, CI: 0.185-0.639, P <0.001; 6th month: OR = 0.418, CI: 0.235-0.744, P = 0.003; 12th month: OR = 0.458, CI: 0.258-0.816, P = 0.008).
In contrast, THC and CFNA were not found to be independent predictors for achieving LDL-C targets or STEMI presentation.
Discussion
This retrospective clinical study is the first to evaluate the long-term outcomes of MI cases categorized based on THC following the 2023 Türkiye earthquake. Previous studies have focused on the incidence, clinical and angiographic characteristics, and in-hospital short-term outcomes of MI cases during the acute phase of the earthquake. However, they have not addressed long-term follow-up outcomes or the impact of THC on health outcomes.Reference Ozturk U23 This study addresses this gap by demonstrating that THC is an independent risk factor for CFNA, total MACE rates, and follow-up attendance rates across all follow-up periods. The findings of this study are generalizable to all disasters that result in large-scale destruction.Reference Kessler24 The development of MACE may affect patient follow-up adherence, making it difficult to accurately evaluate outcomes. Therefore, patients who experienced MACE were excluded from the analysis of CFNA and 1-year clinical outcomes to better assess the impact of THC.
According to guidelines, a change in treatment regimen is recommended at the end of the first year of dual antiplatelet therapy after MI. Dose titration of other cardioprotective drugs (e.g., statins, beta-blockers, ACE inhibitors) is adjusted with regular clinical follow-ups.Reference Byrne, Rossello and Coughlan25 In Türkiye, drug reports for the free supply of these drugs are valid for 1 year. They must be updated by cardiologists at the end of the first year. The highest follow-up attendance rate in both groups was observed at the first-year control visit, probably related to the expiration of the drug report. THC and CFNA were not identified as independent predictors for achieving LDL-C targets. In the 1-year follow-up laboratory results, higher levels of total cholesterol, LDL, and HbA1c in patients with THC can be considered indicators of adverse conditions, poor follow-up, and medication non-adherence. This finding may be attributed to the multifactorial nature and common occurrence of both outcomes.Reference McAllister, Halbesma and Carruthers21, Reference Gitt, Lautsch and Ferrières26
There is no clear consensus on the frequency and timing of follow-up after MI. However, studies and guidelines recommend follow-ups at 14 days and at 1, 3, 6, and 12 months post-discharge to improve medication adherence and reduce the risk of MACE.Reference Virani, Newby and Arnold3–Reference Schiele, Quignot and Khachatryan6 Regular follow-up is essential, particularly for monitoring lipid levels, evaluating cardiac functions, and assessing treatment response.Reference Faridi, Peterson and McCoy27 The clinical follow-up periods of the patients included in this study were planned in accordance with these recommendations.
In the literature, appointment non-adherence is reported to be associated with socioeconomic and psychological factors.Reference Sabouret, Lemesle and Bellemain-Appaix8, Reference Collins, Santamaria and Clayton9 Earthquakes exacerbate these factors, creating additional challenges in accessing health care services.Reference Tsuji and Mateen28 Studies indicate that the adverse effects of THC are associated not only with SDHs but also with biopsychosocial mechanisms.Reference Ellis, McQueenie and McConnachie17, Reference Aldadi, Robb and Williamson29
THC has been associated with factors such as social isolation, loss of loved ones, and injuries, leading to increased rates of suicidal ideation and psychological burnout.Reference Sarı, Taşdelen-Karçkay and Tarcan30–Reference Cetin and Fedai35 These conditions are expected to elevate the risk of CFNA. The consequences of CFNA are as significant as its causes. Regular clinical follow-up reduces MACE rates after MI. Medication adherence, prevention of ischemic events, and management of risk factors are key components of this process.Reference Baky, Moran and Warwick36 However, resource limitations in the health care system following major disasters such as earthquakes negatively impact this process. Earthquakes also increase MI incidence due to elevated stress levels. For instance, MI rates increased by 35% during the Northridge earthquake and tripled during the Hanshin-Awaji earthquake.Reference Kario, Bruce and Thomas37, Reference Leor, Kloner and Investigators38 Increased MI rates hinder access to appointments due to physician shortages, creating a vicious cycle that elevates CFNA and MACE rates.Reference Koshiba, Nishiuchi and Akaihata39, Reference Mitka40 Scheduling follow-up appointments at the time of discharge can eliminate barriers to accessing appointments, reduce adverse outcomes, and improve clinical results.Reference Baky, Moran and Warwick36 To overcome these barriers, walk-in follow-up opportunities were provided to all patients in this study. Temporary housing areas are prefabricated structures used to provide short- and medium-term accommodation. The sustainability of these structures in terms of environmental, economic, and social aspects varies depending on the developmental level of the countries and their disaster management strategies.Reference Montalbano and Santi41 SDHs, such as accessibility to health care services and public transportation routes, directly impact the health outcomes of individuals living in these housing areas.Reference Liao15 Suboptimal housing conditions may negatively affect the clinical prognosis in MI patients by increasing the risk of CFNA.Reference Schepin, Kicha and Goloschapov-Aksenov42
To improve outcomes, phone follow-ups and SMS reminder systems can enhance follow-up adherence in THC patients by overcoming communication and participation barriers in disaster-affected populations. The cause-and-effect relationship between CFNA and THC should be clearly identified, and patient-specific solutions should be explored.Reference Sousa, Cardoso and Vrbová43 In Group 1, elevated HbA1c and reduced e-GFR levels reflect the adverse metabolic effects of THC. Inadequate calorie and fluid intake, increased fast-food consumption, reduced physical activity, and stress-related eating disorders may have contributed to this outcome. Literature suggests that these metabolic disturbances are multifactorial. Therefore, the causal relationship between THC and metabolic outcomes should be further investigated, and post-disaster support for adequate nutrition and access to clean water must be ensured.Reference Takahashi, Yonekura and Tanno44
Conclusion
This study is the first to reveal the independent impact of THC on follow-up adherence and long-term outcomes after MI. Providing accessible health care services and sustainable infrastructure in temporary housing areas can reduce non-adherence and improve long-term outcomes. This study is one of the few that comprehensively examines CFNA as an overall clinical follow-up outcome, in addition to evaluating each follow-up period individually. Improving housing conditions and identifying groups requiring early intervention post-disaster are crucial for reducing long-term mortality and morbidity.
Limitations
The main limitation of the study is its retrospective and single-center design. The relationship between THC and outcomes was not explored in detail, and the reasons for non-adherence to follow-ups were not investigated through direct communication with patients. Additionally, independent factors other than THC that might have contributed should be considered. Therefore, prospective studies comprehensively investigating the causes of follow-up non-adherence are needed. Due to the absence of pre-earthquake epidemiological data, the findings of this study are limited to the patient population presenting to a single post-disaster referral center and may not reflect the overall disease burden across the province. The absence of pre-earthquake incidence data from Hatay and the lack of comparative analysis between Group 2 outcomes and those from non-disaster regions or pre-earthquake Hatay represent important limitations of the study.
Funding statement
The authors declare that they have received no financial support for the study.
Conflict of interests
The authors declare that there is no conflict of interest in the study.
